Valneva SE Ownership
| INRLF Stock | USD 3.01 0.12 4.15% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Valneva |
Valneva Pink Sheet Ownership Analysis
About 18.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Valneva SE had 1108:1000 split on the 15th of January 2015. Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. The company was founded in 1998 and is headquartered in Saint-Herblain, France. Valneva Se is traded on OTC Exchange in the United States.The quote for Valneva SE is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Valneva SE call Thomas Lingelbach at 33 2 28 07 37 10 or check out https://valneva.com.Currently Active Assets on Macroaxis
| VALE | Vale SA ADR | |
| EGY | Vaalco Energy | |
| CMCSA | Comcast Corp | |
| BTE | Baytex Energy Corp | |
| SOXS | Direxion Daily Semiconductor |
Other Information on Investing in Valneva Pink Sheet
Valneva SE financial ratios help investors to determine whether Valneva Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Valneva with respect to the benefits of owning Valneva SE security.